NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of StubHub Holdings, Inc. (NYSE: STUB). Shareholders who purchased shares of STUB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/stubhub-holdings-inc-loss-submission-form/?id=182864&from=3 CLASS PERIOD: Thi ...

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Primo Brands Corporation / Primo Water Corporation (NYSE: PRMB). Shareholders who purchased shares of PRMB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/primo-brands-corporation-primo-water-corporation- ...

NEW YORK, Jan. 5, 2026 /PRNewswire/ --The Gross Law Firm issues the following notice to shareholders of Blue Owl Capital Inc. (NYSE: OWL). Shareholders who purchased shares of OWL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/blue-owl-capital-inc-loss-submission-form/?id=182366&from=4 CLASS PERIOD: February 6, ...

Core Viewpoint - The Gross Law Firm is notifying shareholders of Blue Owl Capital Inc. regarding a class action lawsuit due to alleged misleading statements and undisclosed liquidity issues during a specified class period [1][3]. Group 1: Allegations - The complaint alleges that Blue Owl was under significant pressure on its asset base from redemptions by business development companies [3]. - It is claimed that the company faced undisclosed liquidity issues as a result of these pressures [3]. - The lawsuit suggests that Blue Owl may limit or halt redemptions of certain business development companies due to these liquidity concerns [3]. - Defendants' positive statements about the company's business and prospects are alleged to be materially misleading and lack a reasonable basis [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as February 6, 2025, to November 16, 2025 [3]. - Shareholders are encouraged to register for the class action by February 2, 2026, to potentially be appointed as lead plaintiffs [4]. - There is no cost or obligation for shareholders to participate in the case, and they will receive updates through portfolio monitoring software [4]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Group 1 - The Schall Law Firm is investigating claims on behalf of investors of Air Products and Chemicals, Inc. for potential violations of securities laws [1] - The investigation centers on whether Air Products made false or misleading statements or failed to disclose important information to investors [2] - Following the announcement of negotiations with Yara International to combine industrial gas capabilities, Air Products' shares dropped by 9.45% on December 8, 2025 [2]

NEW YORK, Dec. 22, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of CarMax, Inc. (NYSE: KMX). Shareholders who purchased shares of KMX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/carmax-inc-loss-submission-form/?id=180990&from=3 CLASS PERIOD: June 20, 2025 to November ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of DexCom, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its glucose monitoring products, the G6 and G7, which could pose health risks to users [1]. Group 1: Allegations - The complaint alleges that DexCom made unauthorized design changes to the G6 and G7 glucose monitoring products, which rendered them less reliable than previous versions [1]. - It is claimed that these changes presented a material health risk to users who depend on these devices for accurate glucose readings [1]. - The lawsuit asserts that the enhancements to the G7, including its reliability, accuracy, and functionality, were overstated by the defendants [1]. - The defendants allegedly downplayed the severity of the issues and health risks associated with the altered G7 devices [1]. - The allegations suggest that DexCom faced increased regulatory scrutiny and potential legal, reputational, and financial harm due to these issues [1]. - As a result, the public statements made by the defendants were deemed materially false and misleading throughout the relevant period [1]. Group 2: Class Action Details - The class period for the lawsuit is defined as January 8, 2024, to September 17, 2025, and shareholders are encouraged to register for participation [1][2]. - The deadline for shareholders to seek lead plaintiff status is December 26, 2025, and there is no cost or obligation to participate in the case [2]. - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates on the case's progress [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and engage in good corporate citizenship [3].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Alexandria Real Estate Equities, Inc. regarding violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by January 26, 2026 [1][3]. Group 1: Allegations Against Alexandria - The complaint alleges that Alexandria and its executives made false and misleading statements while failing to disclose adverse facts about the Long Island City property, particularly regarding its leasing value as a life-science destination [3]. - Alexandria's claims about the property were reportedly inconsistent with the actual state of affairs, which could mislead investors [3]. Group 2: Financial Performance - Alexandria reported third quarter earnings for 2025 that fell short of analyst expectations, with a 5% decline in revenue and a 7% decline in adjusted funds from operation [4]. - The average occupancy rate decreased from 94.8% in the previous year to 91.4% [4]. - Following the release of these disappointing financial results, Alexandria's stock price dropped over 19% on October 28, 2025 [4]. Group 3: Legal Proceedings - The lead plaintiff in the class action will be the investor with the largest financial interest who is also typical of class members, overseeing the litigation on behalf of the class [5]. - Any member of the class can apply to serve as lead plaintiff or remain an absent class member without affecting their ability to share in any recovery [5]. Group 4: Call for Information - Faruqi & Faruqi encourages individuals with information regarding Alexandria's conduct, including whistleblowers and former employees, to come forward [6].

Core Viewpoint - Inspire Medical Systems, Inc. is facing a federal securities class action due to allegations of misleading statements regarding the launch and demand for its Inspire V device, leading to significant financial losses for investors [3][5]. Group 1: Allegations and Legal Action - The complaint against Inspire Medical Systems claims that the company and its executives violated federal securities laws by making false or misleading statements about the market demand for the Inspire V device and the steps taken for its launch [3]. - Investors are reminded of the January 5, 2026 deadline to seek the role of lead plaintiff in the class action lawsuit [1][6]. Group 2: Launch Issues and Financial Impact - On August 4, 2025, Inspire Medical announced delays in the launch of the Inspire V device due to incomplete training and onboarding at treatment centers, as well as billing and reimbursement challenges [4]. - The company reported weak demand and excess inventory for the Inspire V, leading to a more than 80% cut in its 2025 earnings guidance [5]. - Following these announcements, Inspire's stock price plummeted over 32% in one day, from $129.95 to $87.91, resulting in a loss of approximately $1.2 billion in market capitalization [5].

NEW YORK, Dec. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Inspire Medical Systems, Inc. (NYSE: INSP). Shareholders who purchased shares of INSP during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: The Gross Law Firm 15 West 38th Street, 12th floor New York, NY, 10018 Email: [email protected] Phone: (646) 453-890 ...